abstract |
The present invention provides animal models for neurodegenerative diseases, in particular, for example, Alzheimer's Disease, which rely on introduction into the brain of a biologically active fragment of acetylcholinesterase of sequence AEFHRWSSYMVHWK (SEQ. ID no.1), or an active variant thereof, to produce brain lesions. |